Literature DB >> 429489

Persistent effect of sustained hyperglucagonemia on glucose production in man.

R A Rizza, J E Gerich.   

Abstract

In man prolonged infusions of glucagon cause a transient increase in glucose production. To determine whether this represents complete loss of effect of hyperglucagonemia on the liver or merely decreased hepatic responsiveness, glucagon (3 ng/kg/min) was infused in six normal subjects to produce sustained hyperglucagonemia for 180 min; at this time glucagon infusions were stopped for 60 min, then restarted at the same rate for 60 min and finally increased to 7.5 ng/kg/min for 30 min. Glucose production (Ra) and utilization (Rd) were measured isotopically. Initially glucagon infusion increased Ra transiently from 1.8 +/- 0.1 mg/kg/min to a maximum at 15 min of 2.5 +/- 0.2 mg/kg/min (p less than .01); Ra returned to basal values by 60 min and remained there until the glucagon infusion was stopped, whereupon it abruptly declined to a nadir of 1.4 +/- 0.1 mg/kg/min, a value significantly below baseline levels, p less than .005. Upon restarting the glucagon infusion, Ra increased to a similar extent as observed with the initial infusion and then returned to basal levels; when the glucagon infusion rate was increased to 7.5 ng/kg/min, Ra again increased. These results indicate that sustained hyperglucagonemia, despite apparent waning of its effect, continues to modulate hepatic glucose production.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429489     DOI: 10.1210/jcem-48-2-352

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  A fuzzy model of glucose regulation.

Authors:  Em Ward; Terry Martin
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.460

2.  Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function.

Authors:  R Assan; S Efendic; R Luft; E Cerasi
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

3.  Prolonged insulin resistance following insulin-induced hypoglycaemia.

Authors:  J N Clore; J R Brennan; S P Gebhart; H H Newsome; J E Nestler; W G Blackard
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

4.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

5.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.

Authors:  R A Rizza; P E Cryer; M W Haymond; J E Gerich
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

Review 7.  Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.

Authors:  Stephanie T Chung; Morey W Haymond
Journal:  J Diabetes Sci Technol       Date:  2014-08-26

8.  Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes.

Authors:  Björn A Menge; Lena Grüber; Signe M Jørgensen; Carolyn F Deacon; Wolfgang E Schmidt; Johannes D Veldhuis; Jens J Holst; Juris J Meier
Journal:  Diabetes       Date:  2011-06-15       Impact factor: 9.461

9.  Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study.

Authors:  Steven E Kahn; Kieren J Mather; Silva A Arslanian; Elena Barengolts; Thomas A Buchanan; Sonia Caprio; David A Ehrmann; Tamara S Hannon; Santica Marcovina; Kristen J Nadeau; Kristina M Utzschneider; Anny H Xiang; Sharon L Edelstein
Journal:  Diabetes Care       Date:  2021-06-15       Impact factor: 17.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.